FR2361900A1 - Nouvelle forme de flunisolide cristallise et ses applications a titre de medicament - Google Patents

Nouvelle forme de flunisolide cristallise et ses applications a titre de medicament

Info

Publication number
FR2361900A1
FR2361900A1 FR7616040A FR7616040A FR2361900A1 FR 2361900 A1 FR2361900 A1 FR 2361900A1 FR 7616040 A FR7616040 A FR 7616040A FR 7616040 A FR7616040 A FR 7616040A FR 2361900 A1 FR2361900 A1 FR 2361900A1
Authority
FR
France
Prior art keywords
flunisolide
crystallized
applications
medicinal product
new form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7616040A
Other languages
English (en)
French (fr)
Other versions
FR2361900B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2361900A1 publication Critical patent/FR2361900A1/fr
Application granted granted Critical
Publication of FR2361900B1 publication Critical patent/FR2361900B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7616040A 1975-05-27 1976-05-26 Nouvelle forme de flunisolide cristallise et ses applications a titre de medicament Granted FR2361900A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130075A 1975-05-27 1975-05-27
US58130175A 1975-05-27 1975-05-27

Publications (2)

Publication Number Publication Date
FR2361900A1 true FR2361900A1 (fr) 1978-03-17
FR2361900B1 FR2361900B1 (enrdf_load_stackoverflow) 1979-04-13

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7616040A Granted FR2361900A1 (fr) 1975-05-27 1976-05-26 Nouvelle forme de flunisolide cristallise et ses applications a titre de medicament

Country Status (15)

Country Link
JP (1) JPS51144719A (enrdf_load_stackoverflow)
AT (1) AT357702B (enrdf_load_stackoverflow)
AU (1) AU506080B2 (enrdf_load_stackoverflow)
CA (1) CA1075228A (enrdf_load_stackoverflow)
DE (2) DE2661037C2 (enrdf_load_stackoverflow)
ES (1) ES448220A1 (enrdf_load_stackoverflow)
FR (1) FR2361900A1 (enrdf_load_stackoverflow)
GB (1) GB1525181A (enrdf_load_stackoverflow)
HK (1) HK8580A (enrdf_load_stackoverflow)
IL (1) IL49652A (enrdf_load_stackoverflow)
MX (1) MX3864E (enrdf_load_stackoverflow)
MY (1) MY8000275A (enrdf_load_stackoverflow)
NL (1) NL191234C (enrdf_load_stackoverflow)
NZ (1) NZ180946A (enrdf_load_stackoverflow)
SE (1) SE421426B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039369A1 (en) * 1980-05-02 1981-11-11 Schering Corporation Beclomethasone ester solvates, process for their preparation, and preparation of a formulation

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE883381A (fr) * 1979-05-21 1980-11-20 Syntex Corp Procede de preparation d'une modification cristalline de flunisolide
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
KR0132576B1 (ko) * 1988-10-05 1998-04-17 로렌스 티. 웰츠 항-용매 내로의 침전을 통한 미분 고형물 결정 분말의 제조 방법
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
EE03509B2 (et) * 1995-06-27 2015-02-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
ATE487506T1 (de) * 1999-03-03 2010-11-15 Optinose As Nasales verabreichungsgerät
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN105188758A (zh) * 2013-03-15 2015-12-23 梅迪奇斯医药公司 氟尼缩松的局部组合物及治疗方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320111A1 (de) * 1972-04-20 1973-10-31 Allen & Hanburys Ltd Solvatisierte, kristalline, antiinflammatorisch wirkende steroide, verfahren zu deren herstellung und diese materialien enthaltende aerosolformulierungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
BE585432A (fr) * 1958-12-08 1960-06-08 American Cyanamid Co Stéroïdes fluorés.
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
DE2332663C2 (de) * 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320111A1 (de) * 1972-04-20 1973-10-31 Allen & Hanburys Ltd Solvatisierte, kristalline, antiinflammatorisch wirkende steroide, verfahren zu deren herstellung und diese materialien enthaltende aerosolformulierungen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039369A1 (en) * 1980-05-02 1981-11-11 Schering Corporation Beclomethasone ester solvates, process for their preparation, and preparation of a formulation

Also Published As

Publication number Publication date
DE2624924C2 (de) 1986-11-27
AU1430176A (en) 1977-12-01
IL49652A (en) 1979-05-31
MX3864E (es) 1981-08-26
DE2624924A1 (de) 1977-12-15
MY8000275A (en) 1980-12-31
ATA388376A (de) 1979-12-15
SE421426B (sv) 1981-12-21
GB1525181A (en) 1978-09-20
JPS6247880B2 (enrdf_load_stackoverflow) 1987-10-09
ES448220A1 (es) 1977-11-01
FR2361900B1 (enrdf_load_stackoverflow) 1979-04-13
SE7605927L (sv) 1976-11-28
IL49652A0 (en) 1976-07-30
NL191234C (nl) 1995-04-03
NL191234B (nl) 1994-11-01
JPS51144719A (en) 1976-12-13
NL7605699A (nl) 1976-11-30
CA1075228A (en) 1980-04-08
AU506080B2 (en) 1979-12-13
HK8580A (en) 1980-03-14
DE2661037C2 (enrdf_load_stackoverflow) 1989-04-06
AT357702B (de) 1980-07-25
NZ180946A (en) 1978-07-28

Similar Documents

Publication Publication Date Title
FR2361900A1 (fr) Nouvelle forme de flunisolide cristallise et ses applications a titre de medicament
Szilagyi et al. Comments on the putative stereoselectivity in cysteine-aldehyde reactions. Selective C (2) inversion and C (4) epimerization in thiazolidine-4-carboxylic acids
FR2377376A1 (fr) Derives d'hexahydroterphenyle et leur application en tant que cristaux liquides
FR2427372A1 (fr) Composes se presentant sous forme de cristaux liquides, leur procede de preparation et dispositif electro-optique en comportant
FR2453148A1 (fr) Nouveaux derives arylsulfinyle d'acide acetohydroxamique, leur procede de preparation et leur application en therapeutique
Chan et al. Absolute configurations of the four warfarin alcohols
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2361359A1 (fr) Nouvelles oximes hydrazones et leur procede de preparation
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
DE3347867C2 (enrdf_load_stackoverflow)
FR2424908A1 (fr) Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant
BE865299A (fr) Nouvelles oximes derivees de l'acide 7-amino-thiazolyl acetamido cephalosporanique, procede de preparation et compositions pharmaceutiques
Milas et al. Studies in Organic Peroxides. VI. Cyclane Peroxides
FR2414509A1 (fr) Procede de cristallisation de cefuroxime sodique
FR2368959A1 (fr) Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament
FR2409254A1 (fr) Procede pour la preparation d'esters de l'acide g-chlorocarboxylique
FR2450246A1 (fr) Procede de separation des isomeres optiques du 1-(o-methoxy-phenoxy)-3-isopropyl-amino-propane-2-ol et compositions pharmaceutiques contenant l'antipode levogyre, utile notamment comme agent b-bloquant
US4216221A (en) 1,3-Disubstituted (2-thio)ureas
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
FR2361898A1 (fr) Forme non hydratee cristalline du 7-(d-2-hydroxy-2-phenyl-acetamido)-3-(1methyl-1h-tetrazole-5-ylthiomethyl)-3-cephem-4-carboxylate de sodium
JPH0372485A (ja) スタウロスポリンの誘導体
JPS62106019A (ja) 抗高脂血症剤
FR2365340A1 (fr) Composition pharmaceutique contenant des phenylglycines l ou dl (racemiques)
PT87433A (pt) Process for the preparation of novel substituted silyl alkyleneamines and of pharmaceutical compositions containing the same
FR2411158A1 (fr) Procede de purification du chlorure de potassium cristallin

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0217, 920519

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0217, 760526

CL Concession to grant licences